...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Provides Update on BETonMACE Phase 3 Trial

RVX management can not know the exact placebo MACE rate. 

The original design was for 8 MACE rate per 100 patient years for placebo, if I remember correctly.  In any case, I am using a hyper conservative 7 rate for placebo.  

If at 7 placebo, we get 40+% RRR. 

Share
New Message
Please login to post a reply